The “Lower Drug Costs Now Act of 2019” (H.R. 3) passed by the House of Representatives—on nearly a party-line vote of 230-192—would endanger patients by leading to a loss of anywhere between 100 to 400 new drugs in the U.S. over the next decade and reduce the average life expectancy of Americans by fourth months, […]

The “Lower Drug Costs Now Act of 2019” (H.R. 3) passed by the House of Representatives—on nearly a party-line vote of 230-192—would endanger patients by leading to a loss of anywhere between 100 to 400 new drugs in the U.S. over the next decade and reduce the average life expectancy of Americans by fourth months, […]